Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
30 Cards in this Set
- Front
- Back
what % of strokes are intracerebral haematoma (haemorrhage)?
|
15%
|
|
What % of case fatality is there within the first month?
|
20-30%
|
|
What portion of stroke survivors are disabled within the 1st year
|
1/3
|
|
Which region of tissue is reversibly injured?
|
penumbra
|
|
what are the two most common causes of acute ischaemic stroke?
|
atherothrombosis and embolism
|
|
atherosclerosis is an
|
inflammatory process
|
|
components of atheroclerotic plaque are
|
inflammatory
|
|
subarachnoid haemorrhage is
|
the rupture of a blood vessel into subarachnoid space
|
|
after SAH there is a risk or
|
re-bleeding or delayed cerebral ischemia (DCI)
|
|
what % is SAH
|
5%
|
|
SAH is generally related to what age group?
|
~50yrs
|
|
the case fatality % of SAH is
|
50%
|
|
inflammation has been proposed to play a role in risk in stroke e.g...
|
plaque progression
destabilisation and thrombo-embolism first stroke/recurrent stroke |
|
inflammation has been proposed to play a role in stroke repair and
|
evolution
|
|
what are the challenges of assessing neuroinflammation in patients?
|
access to CNS tissue
Complexity/cost of imaging equipment assessment of ill/confused patients interpretation and validity |
|
What methods are available for assessment in patients?
|
functional imagine, MRI, PET
brain tissue biopsy evaluate CSF, plasma |
|
MRI involves the injection of..
|
ultrasmall particles of iron oxide
USPIO |
|
USPIO are preferentially phagocytosed by
|
monocytes
|
|
when there is a large amount of infarct injury, there will be a recruitment of
|
monocytes
|
|
PET is the in vivo quantification of..
|
cerebral blood flow, metabolism and receptor binding
|
|
PET involves the injection of a
|
radiolabelled tracer - positron emitting
|
|
11 C-PK11195 is a common PET tracer for
|
microglia activation
|
|
18 F-2-deoxyglucose is a common PET tracer for
|
macrophage activation
|
|
SPECT involves the injection of a
|
radiolabelled tracer - gamma emitting
|
|
what are the limits with examination of brain tissue?
|
limited to post mortem or brain biopsy
ethical/logistical issues |
|
CSF should reflect what is going on in brain more so than bloody why?
|
initimately associated with brain
|
|
CSF tends to be taken from which patients?
|
severe state - selection bias
|
|
What are the limitations with taking CSF?
|
often mixed with blood, hard to tell what came from where
|
|
plasma sampling in acute stroke is useful for what?
|
measuring inflammatory mediators in systemic circulation eg. IL-6 and CRP
|
|
plasma sampling in acute stroke has little value for measuring what
|
mediators released at site of inflammation eg. TNF-a, IL-1
|